Treatment of Unstable Pulmonary Embolism in the Elderly and Those with Comorbid Conditions

2013 ◽  
Vol 126 (4) ◽  
pp. 304-310 ◽  
Author(s):  
Paul D. Stein ◽  
Fadi Matta
2009 ◽  
Vol 84 (1) ◽  
pp. 91-92 ◽  
Author(s):  
Miguel F. Carrascosa ◽  
Ángeles M. Batán ◽  
Marta F.A. Novo

2021 ◽  
pp. 25-28
Author(s):  
Subhash Chand ◽  
Rakesh Chauhan ◽  
Bavesh Barwal

Hyponatremia is a common electrolyte disturbance encountered in hospitals. It is dened as serum concentration <135 meq/l. Various comorbidities predispose to the development of hyponatremia. Patient has symptoms of both hyponatremia as well as comorbidities. This contributes to increased morbidity and mortality .However early recognition and treatment makes prognosis better. Aim: To study clinical features of patients admitted with hyponatremia and investigate them to nd out various aetiologies. Methods And Material: Study was conducted at newly opened medical college at Hamirpur in Himachal Pradesh with limited facilities. A total of 50 patients with symptoms and documented hyponatremia were enrolled in study. Detailed history, clinical examination and laboratory investigations were done. Data thus collected was analysed. Results: Total number of patients was 50. Females were more as compared to males. Mean age of presentation was 67 years and lethargy ,nausea and vomiting were the most common symptoms. Diabetes mellitus and hypertension were the most common comorbidities. Among drugs diuretics were the most commonly used causing hyponatremia. Out of 50 patients 45 patients recovered and ve patients have to be referred because of comorbidities. Conclusions: Hyponatremia is a common problem and clinicians need to be aware of it mainly in the elderly patients. A systemic approach and simple diagnostic algorithm can signicantly improve the outcome in these patients. Treatment of hyponatremia is governed by levels of hyponatremia not by its etiology along with comorbid conditions.


2005 ◽  
Vol 119 (3) ◽  
pp. 169-174 ◽  
Author(s):  
Eric M Genden ◽  
Alessandra Rinaldo ◽  
Ashok R Shaha ◽  
Gary L Clayman ◽  
Jochen A Werner ◽  
...  

As life expectancy increases, surgeons can expect an increasing number of geriatric patients. In turn, the number of elderly patients presenting with head and neck cancer is likely to increase. Management of this subpopulation has become a source of debate because there is a paucity of randomized data regarding the effect of age on treatment response and morbidity associated with the treatment of head and neck cancer. The management of head and neck cancer in the elderly depends on the patient’s age and general condition, the stage of disease, the effects of treatment on quality of life (such as speech and swallowing), patient and family wishes, and active physician participation in continued care. Elderly patient’s comorbid conditions need appropriate attention especially if surgery is to be undertaken. The aim of this review is to examine the current literature in an attempt to develop an approach to the treatment of the elderly patient with head and neck cancer and to define the pertinent issues that require further study.


CHEST Journal ◽  
2009 ◽  
Vol 135 (5) ◽  
pp. 1243-1251 ◽  
Author(s):  
Jeffrey Haspel ◽  
Kenneth Bauer ◽  
Alexander Goehler ◽  
David H. Roberts

Author(s):  
Mara Caroline ◽  
Ryan Bradley ◽  
Mimi Guarneri

The older population is challenging to treat for numerous reasons, including comorbid conditions and increased susceptibility to adverse drug reactions, limiting medical therapy. They are at increased risk for loneliness and depression, which strongly impacts their cardiovascular outcomes, and they also have different values, usually prioritizing quality of life over mortality objectives. Finally, the elderly are underrepresented in cardiovascular clinical trials, thus limiting the applicability of guideline recommendations. This chapter emphasizes the importance of a comprehensive assessment of individual circumstances when assessing cardiovascular health in the elderly population. The chapter focuses on the role of nutrition, resiliency, and exercise for the prevention and treatment of cardiovascular disease. Nutrient deficiencies commonly seen with cardiovascular drugs are also discussed, as well as specific integrative strategies for optimizing dyslipidemia, atrial fibrillation, and heart failure in this population.


Sign in / Sign up

Export Citation Format

Share Document